My thoughts aren't any different than many that have been here. Cash burn needs to go down for r&d and compensation. Not likely for the later. Get Macrilen on the market and work on the bottom line, more revs going in the pot. That's what they need. Some of their inside restructuring on the pipeline has helped. To be clear, I haven't been "in" AEZS for quite some time. Taking a chance that this will be the beginning of their come back story.
News 
Market Data 
Discover 
